Companies / BGT

BIO-GENE TECHNOLOGY LTD

ASX:BGTMaterials
386.1M shares on issueASX (delayed) · as of 28 July 2026$0.018price · delayed$6.8Mmarket cap · indicative
D
Dilution grade

Share count grew 53% in 24 months; 5 cash raises in 24 months; runway 4–8 quarters

Cash runway5.2 quarters of funding
Share-count growth (24m)53.4%
Raise cadence (24m)5 cash raises
Options & rights overhang28.5% of shares
In-the-money supply0.0% of shares
Pending proposed issuesopen proposed issue (Appendix 3B)

BIO-GENE TECHNOLOGY LTD's ordinary share count grew 53.4% between May 2025 and June 2026, to 386M shares. The company raised capital five times in the 24-month window for total disclosed proceeds of A$9.5M, most recently a Placement and Security Purchase Plan (SPP) in June 2026 that raised A$3.3M. Options and rights on issue could convert into 110M new shares, equal to 28.5% of the current share count, with none currently in the money at the prevailing share price; the nearest expiry is May 2028. At the March 2026 quarter the company reported A$2.5M in cash, covering about 5.2 quarters of funding at its recent spending rate. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in July 2026.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
28.5%
Max option dilution
0.0%
ITM option dilution
1
Raises · last 12 months
5.2 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 386.1M per ASX (delayed) (28 July 2026).
240.2M293.7M347.3MDec 24Sept 25July 26Cash raise · 5 June 2026Cash raise · 18 July 2025Cash raise · 5 May 2025Cash raise · 5 May 2025Cash raise · 30 Apr 2025

Cash runway

5.2 qtrs
More than four quarters of funding at the recent spend rate.
$2.5M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
23 June 20262A · quoted issueBGT : ORDINARY FULLY PAID386.1MAppendix 2A
1 June 20262A · quoted issueBGT : ORDINARY FULLY PAID381.3MAppendix 2A
20 July 20253G · unquotedBGT : ORDINARY FULLY PAID266.4MAppendix 3G
20 July 20253H · cancellationBGT : ORDINARY FULLY PAID263.1MAppendix 3H
20 July 20253G · unquotedBGT : ORDINARY FULLY PAID266.4MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

5 cash raises in the last 24 months · 1 in the last 12 months

$3.3M
Placement and Security Purchase Plan (SPP)
5 June 2026 ACTIVE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Join the waitlist

Options & convertible securities

28.5%
Total overhang · of current shares
0.0%
In the money · at current price
110.1M
Potential new shares
May 2028
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
21 July 2025Alex Huong Soo DingBuy33.5M21.7M—3Y notice
21 July 2025Peter MayOther—217k—3Y notice
21 July 2025Timothy GroganOther277k217k—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

6 July 2026Notice of Extraordinary General Meeting/Proxy Form
23 June 2026Result of Security Purchase Plan
23 June 2026Application for quotation of securities - BGT
4 June 2026Update - Proposed issue of securities - BGT
2 June 2026Investor Update Webinar
2 June 2026Launch of Security Purchase Plan
1 June 2026Placement Update and Section 708A(5)(e) Notice
1 June 2026Application for quotation of securities - BGT
1 June 2026Proposed issue of securities - BGT
26 May 2026Proposed issue of securities - BGT
26 May 2026Proposed issue of securities - BGT
26 May 2026Investor Presentation - Placement
25 May 2026$PResults of Placement
21 May 2026$PTrading Halt
20 May 2026BGT to expand Flavocide and Qcide evaluation to Asia
5 May 2026Key insecticide combinations patent allowed in the US
27 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
19 Apr 2026Investor Presentation
13 Apr 2026Change of Auditor
26 Mar 2026NWR Healthcare Conference Presentation

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.